Dipanjan Sengupta

Title: The Innovative Contributions of Dipanjan Sengupta

Introduction

Dipanjan Sengupta is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds and processes. With a total of 17 patents to his name, Sengupta's work has the potential to impact various medical treatments.

Latest Patents

Sengupta's latest patents include groundbreaking inventions such as crystalline forms of a menin inhibitor. This invention describes crystalline forms of (S)-4-methyl-5-((4-((2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)methyl)-1-(2-(4-(methylsulfonyl)piperazin-1-yl)propyl)-1H-indole-2-carbonitrile or solvate thereof. Another notable patent involves processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof. This invention relates to processes and intermediates useful in the preparation of an S1P1 receptor modulator, which is beneficial in treating various disorders, including autoimmune diseases, inflammatory conditions, and cancer.

Career Highlights

Throughout his career, Sengupta has worked with notable companies such as Arena Pharmaceuticals, Inc. and Dart Neuroscience Ltd. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in pharmaceutical research.

Collaborations

Sengupta has collaborated with talented individuals in the field, including Tawfik Gharbaoui and Ashwin M Krishnan. These collaborations have fostered an environment of innovation and creativity, leading to the development of impactful inventions.

Conclusion

Dipanjan Sengupta's contributions to the field of pharmaceuticals through his numerous patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.